With advances in genomic exploration over the past two decades, some germline variants have been described as associated with an increased risk of breast cancer, such as pathogenic variants (PVs) in the BRCA1, BRCA2, PALB2, TP53 and ATM genes [4]. The gene discussed is BRCA2; the disease is breast carcinoma.